Chronic Kidney Disease(CKD)
Conditions
Brief summary
This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.
Interventions
Patients in the interventional group received medication reconciliation at admission and discharge in addition to continuous medication review during their admissions.
Sponsors
Study design
Intervention model description
This was a quasi-experimental trial
Eligibility
Inclusion criteria
* Adult (18 years or older) admitted patients with CKD (stages 2-5 ), who were using at least three chronic medicines at home, and were hospitalized for at least 48 hours.
Exclusion criteria
* Patients with kidney transplantation . * Patients who have difficulties in responding to interviews and did not have family member or caregiver on behave. * Patients who refused to provide a written informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| all-cause 90-day readmission | 90 days after discharge | The primary outcome in this study was the likelihood of all-cause 90-day readmission as extracted from medical records for both study groups |
Countries
Jordan